Swiss National Bank
AVXL icon

Swiss National Bank’s Anavex Life Sciences AVXL Stock Holding History

Swiss National Bank’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-164,400
Closed -$585K – 2309
2025
Q4 		$585K Hold
164,400
– – ﹤0.01% 2271
2025
Q3 		$1.46M Hold
164,400
– – ﹤0.01% 1996
2025
Q2 		$1.52M Hold
164,400
– – ﹤0.01% 1945
2025
Q1 		$1.41M Buy
+164,400
New +$1.55M ﹤0.01% 1962
2024
Q2 		– Sell
-161,500
Closed -$822K – 2471
2024
Q1 		$822K Hold
161,500
– – ﹤0.01% 2314
2023
Q4 		$1.5M Sell
161,500
-16,200
-9% -$112K ﹤0.01% 2005
2023
Q3 		$1.16M Buy
177,700
+4,400
+3% +$35K ﹤0.01% 2155
2023
Q2 		$1.41M Buy
173,300
+5,000
+3% +$42.8K ﹤0.01% 2116
2023
Q1 		$1.44M Sell
168,300
-19,900
-11% -$199K ﹤0.01% 2040
2022
Q4 		$1.74M Buy
188,200
+4,600
+3% +$49.1K ﹤0.01% 1980
2022
Q3 		$1.9M Buy
183,600
+4,100
+2% +$43.3K ﹤0.01% 1908
2022
Q2 		$1.8M Buy
179,500
+8,700
+5% +$82.4K ﹤0.01% 1998
2022
Q1 		$2.1M Buy
170,800
+12,600
+8% +$155K ﹤0.01% 2011
2021
Q4 		$2.74M Buy
158,200
+11,600
+8% +$220K ﹤0.01% 1841
2021
Q3 		$2.63M Hold
146,600
– – ﹤0.01% 1874
2021
Q2 		$3.35M Buy
+146,600
New +$2.17M ﹤0.01% 1768

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Swiss National Bank's AVXL Position: Q1 2026 in Review

Swiss National Bank sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 164,400 shares — an estimated $585K sold.

Swiss National Bank first reported a position in AVXL in Q2 2021 and held it in 16 quarters. The position peaked at $3.35M in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Swiss National Bank reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Swiss National Bank sold 164,400 Anavex Life Sciences shares in Q1 2026, an estimated $585K.
  • Swiss National Bank first reported a position in Anavex Life Sciences in Q2 2021 and held it in 16 quarters.
  • Swiss National Bank's Anavex Life Sciences position peaked at $3.35M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.